Status:

COMPLETED

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

Lead Sponsor:

Copenhagen Trial Unit, Center for Clinical Intervention Research

Collaborating Sponsors:

Danish Heart Foundation

Copenhagen Hospital Corporation

Conditions:

Heart Disease

Cardiovascular Disease

Eligibility:

All Genders

18-84 years

Phase:

PHASE3

Brief Summary

A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with...

Detailed Description

Basic science suggests a fundamental role for inflammation in mediating all stages of coronary heart disease (CHD), and a large number of clinical studies have reported an association between markers ...

Eligibility Criteria

Inclusion

  • patients aged 18 to 85 years and
  • previous acute myocardial infarction (AMI) or
  • previous or present angina pectoris and
  • signed informed concent

Exclusion

  • AMI or unstable angina pectoris within the last three months
  • revascularisation (PTCA or CABG) within the preceding six months
  • severe heart failure (New York Heart Association (NYHA) functional class IV)
  • known impaired renal or hepatic function
  • active malignancy
  • intolerance to macrolides
  • treatment with methylxanthines, carbamazepine, cisapride, astemizole, terfenadine, or coumarin anticoagulants
  • earlier inclusion in the CLARICOR Trial or participation in another drug trial within four weeks
  • participation in other clinical trials within one month before this trial
  • individuals incapable of managing own affairs or not able to sign written consent
  • lack of written consent
  • women of childbearing age not using reliable contraceptives
  • breast feeding women

Key Trial Info

Start Date :

October 1 1999

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2002

Estimated Enrollment :

4372 Patients enrolled

Trial Details

Trial ID

NCT00121550

Start Date

October 1 1999

End Date

September 1 2002

Last Update

August 11 2016

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9

Copenhagen, Denmark, 2100

2

H:S Rigshospitalet

Copenhagen, Denmark, 2100

3

H:S Amager Hospital

Copenhagen, Denmark, 2300

4

H:S Bispebjerg Hospital

Copenhagen, Denmark, 2400